Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

SWAP-70 Inhibitors

SWAP70 inhibitors encompass a collection of compounds that can modulate the function of SWAP70 through their actions on various signaling pathways and elements of the cytoskeleton, particularly those involved in the actin dynamics. The inhibitors listed do not bind directly to SWAP70 but influence its activity by altering the cellular context within which SWAP70 operates. For instance, PI3K inhibitors like LY294002 and Wortmannin disrupt phosphatidylinositol 3-kinase activity, a pivotal node in the signaling network that impacts cell survival and migration. The inhibition of PI3K alters the downstream AKT signaling cascade, which has a consequential effect on actin reorganization processes that SWAP70 is known to be a part of. Similarly, MEK inhibitor PD98059 and p38 MAPK inhibitor SB203580 impact the mitogen-activated protein kinase pathways, which are instrumental in regulating cellular responses to stress and inflammation, thus indirectly influencing SWAP70's role within these pathways.

The actin cytoskeleton is a critical component of cell structure and movement, and SWAP70's role in regulating this dynamic structure places it at the nexus of multiple regulatory pathways that can be modulated by the inhibitors listed. Cytochalasin D and Latrunculin A disrupt the polymerization of actin filaments, while Blebbistatin and Jasplakinolide act on myosin and stabilize actin filaments, respectively, thus demonstrating the diverse ways in which the actin cytoskeleton can be targeted to influence SWAP70's function. Other inhibitors, such as ML141 and NSC23766, target small GTPases like Cdc42 and Rac1, which are known to interact with SWAP70 and are critical regulators of actin polymerization and cell morphology. By modulating these GTPases, these inhibitors can affect the upstream signaling that contributes to the regulation of SWAP70. Additionally, CK-666, as an Arp2/3 complex inhibitor, offers a unique approach by targeting a key actin nucleation center, thereby altering the broader actin network architecture and potentially the activity of SWAP70 in actin filament branching and organization. Collectively, these inhibitors provide a multifaceted approach to modulating the function of SWAP70, capitalizing on its integration into cellular signaling and structural pathways to achieve modulation of its activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that can affect the downstream signaling involved in actin remodeling, which may influence SWAP70 activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Another PI3K inhibitor that can alter the PI3K-AKT pathway, indirectly affecting SWAP70's role in the cytoskeleton organization.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that can modulate the MAPK/ERK pathway, potentially affecting the signaling pathways where SWAP70 is active.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor which might alter the cellular response in which SWAP70 is a participant.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Cdc42 inhibitor, given that SWAP70 interacts with Cdc42, this compound may impact its activity.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$315.00
$1020.00
5
(0)

Arp2/3 complex inhibitor that can affect the actin network, thus indirectly affecting SWAP70 function.